GPC3 and neoplasm: As shown in Fig. 5a, similar to HepG2 tumor lysates, these two GPC3 and PEG10 precursor peptides complexed with recombinant gp96 exhibited specific cytotoxicity for HepG2 cells but not for SK-Hep-1 cells.